These companies could innovate their way to success.
High-quality genome assemblies and CRISPR editing were used in goldenberries to generate more compact and manageable plants.
Gene-edited goldenberries clear USDA review, moving closer to farms. Compact plants solve farming challenges for this ...
A research team has developed a serum-free system combined with CRISPR/Cas gene editing that enables long-term expansion and efficient muscle differentiation of porcine satellite cells, laying the ...
Karthik and her team aimed to use CRISPR as a way to identify and isolate a protein generated by the bacteria that cause Lyme ...
Gain insights into the U.S. market, valued at $5.9 Billion in 2024, and China, forecasted to grow at an impressive 14.4% CAGR to reach $7.8 Billion by 2030. Discover growth trends in other key regions ...
Chicago-based CRISPR technology company Syntax Bio says it has developed tech which automates the slow, manual process of ...
To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results